302 related articles for article (PubMed ID: 24529196)
1. Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.
Zhang X; Xiang C; Zhou YH; Jiang A; Qin YY; He J
BMC Cardiovasc Disord; 2014 Feb; 14():19. PubMed ID: 24529196
[TBL] [Abstract][Full Text] [Related]
2. Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Lin YC; Lai TS; Wu HY; Chou YH; Chiang WC; Lin SL; Chen YM; Chu TS; Tu YK
Clin Pharmacol Ther; 2020 Oct; 108(4):833-843. PubMed ID: 32320058
[TBL] [Abstract][Full Text] [Related]
3. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
4. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.
Hou W; Lv J; Perkovic V; Yang L; Zhao N; Jardine MJ; Cass A; Zhang H; Wang H
Eur Heart J; 2013 Jun; 34(24):1807-17. PubMed ID: 23470492
[TBL] [Abstract][Full Text] [Related]
5. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
[TBL] [Abstract][Full Text] [Related]
6. HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Jul; (3):CD004289. PubMed ID: 19588351
[TBL] [Abstract][Full Text] [Related]
7. Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.
Storey BC; Staplin N; Haynes R; Reith C; Emberson J; Herrington WG; Wheeler DC; Walker R; Fellström B; Wanner C; Landray MJ; Baigent C;
Kidney Int; 2018 Apr; 93(4):1000-1007. PubMed ID: 29146277
[TBL] [Abstract][Full Text] [Related]
8. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Apr; (2):CD005019. PubMed ID: 19370615
[TBL] [Abstract][Full Text] [Related]
9. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
[TBL] [Abstract][Full Text] [Related]
10. A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes.
Khan SU; Talluri S; Riaz H; Rahman H; Nasir F; Bin Riaz I; Sattur S; Ahmed H; Kaluski E; Krasuski R
Eur J Prev Cardiol; 2018 May; 25(8):844-853. PubMed ID: 29569492
[TBL] [Abstract][Full Text] [Related]
11. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.
Palmer SC; Craig JC; Navaneethan SD; Tonelli M; Pellegrini F; Strippoli GF
Ann Intern Med; 2012 Aug; 157(4):263-75. PubMed ID: 22910937
[TBL] [Abstract][Full Text] [Related]
12. Postponement of cardiovascular outcomes by statin use: A systematic review and meta-analysis of randomized clinical trials.
Hansen MR; Hróbjartsson A; Pottegård A; Damkier P; Madsen KG; Pareek M; Olesen M; Hallas J
Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):286-296. PubMed ID: 32896109
[TBL] [Abstract][Full Text] [Related]
13. Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis.
Riaz H; Khan SU; Rahman H; Shah NP; Kaluski E; Lincoff AM; Nissen SE
Eur J Prev Cardiol; 2019 Mar; 26(5):533-543. PubMed ID: 30861690
[TBL] [Abstract][Full Text] [Related]
14. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis.
de Vries FM; Denig P; Pouwels KB; Postma MJ; Hak E
Drugs; 2012 Dec; 72(18):2365-73. PubMed ID: 23186103
[TBL] [Abstract][Full Text] [Related]
15. Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
Vallejo-Vaz AJ; Ray KK; Ginsberg HN; Davidson MH; Eckel RH; Lee LV; Bessac L; Pordy R; Letierce A; Cannon CP
Atherosclerosis; 2019 Sep; 288():85-93. PubMed ID: 31349086
[TBL] [Abstract][Full Text] [Related]
16. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
Tenenbaum A; Fisman EZ
Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
[TBL] [Abstract][Full Text] [Related]
17. Effects of statin treatment in patients with coronary artery disease and chronic kidney disease.
Kaneko H; Yajima J; Oikawa Y; Tanaka S; Fukamachi D; Suzuki S; Sagara K; Otsuka T; Matsuno S; Funada R; Kano H; Uejima T; Koike A; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
Heart Vessels; 2014 Jan; 29(1):21-8. PubMed ID: 23430269
[TBL] [Abstract][Full Text] [Related]
18. High-intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysis.
Yan YL; Qiu B; Wang J; Deng SB; Wu L; Jing XD; Du JL; Liu YJ; She Q
BMJ Open; 2015 May; 5(5):e006886. PubMed ID: 25979868
[TBL] [Abstract][Full Text] [Related]
19. Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.
Rysz J; Gluba-Brzózka A; Banach M; Więcek A
Int Urol Nephrol; 2015 May; 47(5):805-13. PubMed ID: 25758011
[TBL] [Abstract][Full Text] [Related]
20. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
Cai T; Abel L; Langford O; Monaghan G; Aronson JK; Stevens RJ; Lay-Flurrie S; Koshiaris C; McManus RJ; Hobbs FDR; Sheppard JP
BMJ; 2021 Jul; 374():n1537. PubMed ID: 34261627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]